Literature DB >> 18923965

Development of a partial Balint's syndrome in a congenitally deaf patient presenting as pseudo-aphasia.

Daniel L Drane1, Gregory P Lee, Justin S Huthwaite, David L Tirschwell, Brett C Baudin, Miguel Jurado, Basavaraj Ghodke, Holmes B Marchman.   

Abstract

We present a 56 year-old, right-handed, congenitally deaf female who exhibited a partial Balint's syndrome accompanied by positive visual phenomena restricted to her lower right visual quadrant (e.g., color band, transient unformed visual hallucinations). Balint's syndrome is characterized by a triad of visuo-ocular symptoms that typically occur following bilateral parieto-occipital lobe lesions. These symptoms include the inability to perceive simultaneous events in one's visual field (simultanagnosia), an inability to fixate and follow an object with one's eyes (optic apraxia), and an impairment of target pointing under visual guidance (optic ataxia). Our patient exhibited simultanagnosia, optic ataxia, left visual field neglect, and impairment of all complex visual-spatial tasks, yet demonstrated normal visual acuity, intact visual fields, and an otherwise normal neurocognitive profile. The patient's visuo-ocular symptoms were noticed while she was participating in rehabilitation for a small right pontine stroke. White matter changes involving both occipital lobes had been incidentally noted on the CT scan revealing the pontine infarction. As the patient relied on sign language and reading ability for communication, these visuo-perceptual limitations hindered her ability to interact with others and gave the appearance of aphasia. We discuss the technical challenges of assessing a patient with significant barriers to communication (e.g., the need for a non-standardized approach, a lack of normative data for such special populations), while pointing out the substantial contributions that can be made by going beyond the standard neuropsychological test batteries.

Entities:  

Mesh:

Year:  2008        PMID: 18923965      PMCID: PMC2836810          DOI: 10.1080/13854040802448718

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  12 in total

Review 1.  Psychoanatomical substrates of Bálint's syndrome.

Authors:  M Rizzo; S P Vecera
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Rehabilitation of Balint's syndrome: a single case report.

Authors:  M Rosselli; A Ardila; C Beltran
Journal:  Appl Neuropsychol       Date:  2001

3.  Balint's syndrome in a 10-year-old male.

Authors:  Jennifer A Gillen; Gordon N Dutton
Journal:  Dev Med Child Neurol       Date:  2003-05       Impact factor: 5.449

Review 4.  [Balint's syndrome--visual disorientation].

Authors:  H Udesen; A L Madsen
Journal:  Ugeskr Laeger       Date:  1992-05-18

5.  Simultanagnosia. To see but not two see.

Authors:  H B Coslett; E Saffran
Journal:  Brain       Date:  1991-08       Impact factor: 13.501

6.  Balint's syndrome arising from bilateral posterior cortical atrophy or infarction: rehabilitation strategies and their limitation.

Authors:  F M Perez; R S Tunkel; E A Lachmann; W Nagler
Journal:  Disabil Rehabil       Date:  1996-06       Impact factor: 3.033

7.  Looking but not seeing: attention, perception, and eye movements in simultanagnosia.

Authors:  M Rizzo; R Hurtig
Journal:  Neurology       Date:  1987-10       Impact factor: 9.910

Review 8.  Spatial hemineglect in humans.

Authors:  G Kerkhoff
Journal:  Prog Neurobiol       Date:  2001-01       Impact factor: 11.685

9.  The association between neuropsychological scores and ethnicity, language, and acculturation variables in a large patient population.

Authors:  Kyle Brauer Boone; Tara L Victor; Johnny Wen; Jill Razani; Marcel Pontón
Journal:  Arch Clin Neuropsychol       Date:  2007-02-22       Impact factor: 2.813

10.  Effects of parietal injury on covert orienting of attention.

Authors:  M I Posner; J A Walker; F J Friedrich; R D Rafal
Journal:  J Neurosci       Date:  1984-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.